RIC8B Antibody [Janelia Fluor® 646]
Novus Biologicals, part of Bio-Techne | Catalog # NBP3-46734JF646

Conjugate
Catalog #
Forumulation
Catalog #
Key Product Details
Species Reactivity
Human, Mouse, Rat
Applications
ELISA, Immunohistochemistry, Western Blot
Label
Janelia Fluor 646
Antibody Source
Polyclonal Rabbit IgG
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
resistance to inhibitors of cholinesterase 8 homolog B(C. elegans). (Uniprot# Q9NVN3)
Clonality
Polyclonal
Host
Rabbit
Isotype
IgG
Applications for RIC8B Antibody [Janelia Fluor® 646]
Application
Recommended Usage
ELISA
Optimal dilutions of this antibody should be experimentally determined.
Immunohistochemistry
Optimal dilutions of this antibody should be experimentally determined.
Western Blot
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Immunogen affinity purified
Formulation
50mM Sodium Borate
Preservative
0.05% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: RIC8B
Alternate Names
Brain synembrin, hSyn, Protein Ric-8B, RIC8, RIC8B resistance to inhibitors of cholinesterase 8 homolog B (C. elegans), synembryn, synembryn-B
Gene Symbol
RIC8B
Additional RIC8B Products
Product Documents for RIC8B Antibody [Janelia Fluor® 646]
Product Specific Notices for RIC8B Antibody [Janelia Fluor® 646]
Sold under license from the Howard Hughes Medical Institute, Janelia Research Campus.
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...